Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
500 participants
INTERVENTIONAL
2023-06-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Virtual Reality Exposure Therapy to Prolonged Exposure
NCT01459705
Gaze-Contingent Music Therapy Augmentation of CBT for Pediatric Anxiety
NCT06595953
A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder
NCT00978484
Virtual Reality and Post Traumatic Stress
NCT06684977
Addressing Anxiety in 2-3-Year-Olds: A Pilot Intervention Study
NCT04039243
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual Reality
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Virtual Reality headset with calming scenery
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Control
No intervention (i.e. virtual reality headset) will be applied to the participant.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Virtual Reality headset with calming scenery
Participants will be immersed in a virtual environment. Calming scenery will be shown via the headset for 20-30 minutes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to consent
* Parents whose child is undergoing various procedures at LPCH and Stanford Hospital and Clinics.
Exclusion Criteria
* Significant Cognitive Impairment
* History of Severe Motion Sickness
* Current Nausea
* Seizures
* Visual Problems
* Patients whose children are clinically unstable or require urgent/emergent intervention
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Caruso
Clinical Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lucile Parkard Children's Hospital
Stanford, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Thomas J Caruso, MD, PhD
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Chang ZY, Kang GC, Koh EYL, Fong RJK, Tang J, Goh CK, Tan NC. Immersive Virtual Reality in Alleviating Pain and Anxiety in Children During Immunization in Primary Care: A Pilot Randomized Controlled Trial. Front Pediatr. 2022 Mar 25;10:847257. doi: 10.3389/fped.2022.847257. eCollection 2022.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69068
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.